Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
C4025 CEP-28122Summary: anaplastic lymphoma kinase (ALK) inhibitor -
C4363 Rp-8-bromo-Cyclic GMPS (sodium salt)Summary: cGMP-dependent protein kinase (cGK) inhibitor -
C4394 Rp-8-pCPT-Cyclic GMPS (sodium salt)Summary: GMP-dependent protein kinases (cGKs) inhibitor -
C4727 4-methyl ErlotinibSummary: EGFR inhibitor -
C4281 SR 0987Summary: agonist of the T cell-specific isoform of RORγ -
C4439 PKR InhibitorSummary: double-stranded RNA-activated protein kinase (PKR) inhibitor -
C4541 LDN-211904Summary: inhibitor of erythropoietin-producing hepatocellular carcinoma (Eph) receptors -
C4539 AG-370Summary: PDGFR inhibitor -
C4603 VEGFR Tyrosine Kinase Inhibitor II1 CitationSummary: VEGFR inhibitor -
C4760 AG-82Summary: inhibitor of EGFR kinase

